ENDRA is working to solve global healthcare challenges by expanding the utility of ultrasound. We are passionate about broadening access to better healthcare.
Chief Executive Officer and Chairman
Francois Michelon joined ENDRA as chief executive officer and chairman of the board of directors in 2015. He has 20 years of healthcare technology experience in general management, operations, strategy and marketing across the diagnostic imaging, surgical instrument and dental sectors.
From 2012 to 2014, Michelon served as vice president of global marketing for the 3i division of Biomet, Inc. (now Zimmer Biomet Holdings, Inc.), a provider of oral reconstruction technologies, where he was responsible for the upstream and downstream development of the division’s global portfolio. From 2004 to 2011, Michelon served as group director of global services and visualization for Smith & Nephew plc’s Advanced Surgical Devices division, where he led P&L’s in the B2B service and capital equipment sectors. From 1997 to 2004, Michelon worked at GE Healthcare in a variety of global upstream and downstream marketing roles.
Michelon received an M.B.A. from Carnegie-Mellon University and a bachelor’s in economics from the University of Chicago. He has also earned his Six Sigma Black Belt certification.
Chief Technology Officer
Prior to joining ENDRA as chief technology officer in 2007, Michael Thornton was a founder and president of Enhanced Vision Systems Corp., or EVS, a developer and supplier of medical imaging equipment to the pharmaceutical, biotech and academic sectors.
In 2002, EVS was acquired by General Electric Company. Following the acquisition of EVS by GE, Thornton held a number of positions at GE Healthcare, including sales manager, global product manager and site leader. He was a member of the leadership team that expanded the pre-clinical imaging business to include: computed tomography, optical and positron emission tomography imaging technologies, with global market reach. He is also a founder of Volumetrics Medical Corp., a developer and manufacturer of quality assurance devices for diagnostic imaging.
Prior to founding EVS, Thornton developed medical imaging related technologies at the Robarts Research Institute (London, Ontario, Canada) for which he obtained a master’s in electrical engineering from the University of Western Ontario. Thornton also holds a bachelor’s in electrical engineering from the University of Toronto and is a member of the American Association of Physicists in Medicine.
Chief Financial Officer
David Wells became ENDRA’s chief financial officer in 2014. He possesses 30 years of experience in finance, operations and administrative positions. While mainly focused on technology companies, Wells has also worked in the water treatment, supply-chain management, manufacturing and professional services industries.
Wells is the founder of Wells Compliance Group, a technology-based services firm supporting the financial reporting needs of publicly traded companies and privately held firms whose investor or shareholder base requires timely GAAP-compliant financial reporting. Wells has been the chief executive officer of StoryCorp Consulting (d/b/a Wells Compliance Group) since March 2013. In this role, Wells has served as the principal financial officer of several emerging growth companies, including Mount Tam Biotechnologies, Inc., a biopharmaceutical company (August 2015 to April 2016), Content Checked Holdings, Inc., a technology company (April 2015 to present) and Loton, Corp., a media company (February 2016 to present). From 2009 to 2013, he was the president, CFO and a director of Sionix Corporation, a publicly traded water treatment company.
Wells holds an M.B.A. from Pepperdine University and a bachelor’s in finance and entrepreneurship from Seattle Pacific University.
Vice President of Engineering and Programs
Amy Sitzler is ENDRA’s Vice President of Engineering and Programs, overseeing clinical product development, Ann Arbor site operations and company-wide quality systems. Amy joined ENDRA in May 2018 with over thirty five years of experience in engineering, program management and quality systems implementation. Her career includes 20 years at GE Healthcare and over 15 years leading her own consultancy, where she assumed senior roles in quality and engineering for clients such as Sidel and Thermo Fisher Scientific. At GE, Amy’s roles included a 5 year assignment in France leading a 200 person global engineering team that introduced the first digital mammography product. She was also a GE Quality Champion, leading Six Sigma implementation for all Engineering groups at GE Healthcare in US, France and Japan.
Amy is fluent in French and holds a B.S in Applied Mathematics from The Indiana University of Pennsylvania, and an MBA from Marquette University.
Human Resources Leader
Steve Freeman joined ENDRA as human resources leader in May 2017. His background includes 15 years of large company HR leadership roles prior to founding a human capital consulting firm focused on outsourced and fractional services for small and mid-sized companies.
His experience includes leadership roles with NCR, Scientific-Atlanta, Cardinal Health and General Electric in manufacturing, aviation, medical, consumer services, high-tech, distribution and financial services in addition to helping hundreds of industry-diverse organizations as a consultant. Freeman is known for his expertise in talent management, workforce planning, organization and leadership development and acquisition and integration planning.
Freeman received a bachelor’s in industrial and labor relations from Cornell University and an M.B.A. from Georgia State University. He holds a lifetime certification as a Senior Professional in Human Resources (SPHR) and is green belt certified.
Chief Commercial Officer
Renaud Maloberti joined ENDRA in May 2019 as chief commercial officer. He brings over 20 years of global commercial experience in medical imaging, including 12 years in ultrasound. Most recently, Maloberti was CCO of Bionik Laboratories, a company in the AI enhanced rehabilitation robotics market. From 2012 to 2018, Maloberti held various positions at FujiFilm SonoSite Inc., most recently as vice president and general manager of the SonoSite High Frequency division, where he led the development and launch of the world's first ultra-high frequency ultrasound and led the division through double-digit revenue growth for six years.
Maloberti previously served as general manager, Americas for BK Medical Systems, the ultrasound subsidiary of Analogic Corporation (Nasdaq: ALOG). Earlier in his career, Maloberti worked at Draeger Medical Systems, a leader in patient monitoring and healthcare IT systems. Maloberti also spent 10 years in sales and marketing roles at GE Healthcare, a global leader in diagnostic imaging, healthcare IT systems and services.
Maloberti holds an M.B.A. in global marketing from Babson College and a bachelor’s degree in International Finance from ESLSCA Business School in Paris, France. He is fluent in English and French.
Lou Basenese joined ENDRA's board of directors in 2020. Basenese, 42, is the Founder and Chief Analyst of Disruptive Tech Research, LLC, an independent equity research and advisory firm focused exclusively on disruptive technology companies that has served the investment management community since June 2014. Since 2005, Basenese has also managed The Basenese Group, LLC, a consulting business focused on communications and business development for private and public small and microcap businesses. Mr. Basenese holds an M.B.A. in Finance from the Crummer Graduate School of Business at Rollins College and a Bachelor of Arts from the University of Florida. He is also a former Series 7 and Series 66 license holder.
Anthony DiGiandomenico joined ENDRA’s board of directors in 2013. A co-founder of MDB Capital Group LLC, DiGiandomenico focuses on corporate finance and capital formation for growth-oriented companies. He has participated in all areas of corporate finance including private capital, public offerings, PIPEs, business consulting and strategic planning and mergers and acquisitions.
DiGiandomenico has also worked on a wide range of transactions for growth-oriented companies in the biotechnology, nutritional supplements, manufacturing and entertainment industries. Prior to forming MDB Capital Group LLC in 1997, Mr. DiGiandomenico served as president and CEO of the Digian Company, a real estate development company.
DiGiandomenico holds an M.B.A. from the Haas School of Business at the University of California, Berkeley and a bachelor’s in finance from the University of Colorado.
Dr. Sanjiv Sam Gambhir joined our board of directors in 2008. He is the Virginia & D.K. Ludwig Professor of Cancer Research and the chair of radiology at Stanford University School of Medicine. He also heads the Canary Center at Stanford for Cancer Early Detection and directs the Molecular Imaging Program at Stanford (MIPS).
He received an M.D. and Ph.D. from the UCLA Medical Scientist Training Program. He has many publications in the field and numerous patents pending or granted. He has developed and clinically translated several multimodality molecular imaging strategies including imaging of gene and cell therapies. He has also pioneered imaging areas such as Bioluminescence Resonance Energy Transfer (BRET), split-reporter technology, Raman imaging in vivo, Molecular Photoacoustic imaging, PET reporter genes, and novel in vitro and in vivo strategies for the early detection of cancer.
Dr. Gambhir serves on numerous academic advisory boards for universities around the world and also served as a member of the Board of Scientific Advisors of the National Cancer Institute from 2004 to 2012. He has also founded or co-founded several startups in the diagnostics space. Among his many awards are the George Von Hevesy Prize and the Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science from the Society of Nuclear Medicine, Outstanding Researcher Award from the Radiological Society of Northern America, the Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation, the Holst Medal, the Tesla Medal and the Hounsfield Medal from Imperial College, London. He was elected to the Institute of Medicine of the U.S. National Academies in 2008.
Michael Harsh joined ENDRA’s board of directors in 2015. He has 36 years’ experience in healthcare technology, focused on diagnostic imaging. Harsh was most recently GE Healthcare’s vice president and chief technology officer, leading its global science and technology organization and research and development teams in diagnostics, healthcare IT and life sciences.
In 2004, Harsh was named global technology leader—Imaging Technologies Lab at the GE Global Research Center, where he led the research for imaging technologies across the company as well as the research associated with computer visualization/image analysis and superconducting systems. He led the Engineering division for GE Industrial and Enterprise Solutions from 2006 to 2009. Harsh was named an officer of General Electric Company in November 2006. He is a co-founder and current chief product officer of Terapede Systems Inc., a digital x-ray detector startup, a member of the board of directors of FloDesign Sonics, Inc., a member of the Scientific Advisory Board of Phoenix Nuclear Labs, LLC and a consultant to start-ups in the medical device industry.
Harsh is a graduate of Marquette University, where he earned a bachelor’s degree in electrical engineering. He holds numerous U.S. patents in the field of medical imaging and instrumentation. In 2008, Harsh was elected to the American Institute for Medical and Biological Engineering College of Fellows for his significant contributions to the medical and biological engineering field.
Alexander Tokman joined ENDRA’s board of directors in 2008. He is currently CEO-In-Residence at the Allen Institute for Artificial Intelligence (AI2). From 2006 to 2017 he served as president, chief executive officer and a director of Microvision, Inc., a publicly traded laser beam scanning projection and imaging company.
Previously, Tokman completed a 10+ year tenure as an executive with GE Healthcare, where he led several global businesses, most recently as a general manager of its Global Molecular Imaging and Radiopharmacy multi-technology business unit from 2003 to 2005. Between 1995 and 2003, Tokman served in various leadership roles at GE Healthcare, where he led the definition and successful commercialization of several product segments, including PET/CT, which generated over $500 million of revenue within the first three years of its launch. From 1989 to 1995, Mr. Tokman served as development programs lead and a head of industry and regional development at Tracor Applied Sciences.
Tokman has both a master’s and a bachelor’s in electrical engineering from the University of Massachusetts, Dartmouth. He is a certified Six Sigma and Design for Six Sigma (DFSS) Black Belt and Master Black Belt and as one of General Electric Company’s Six Sigma pioneers, he drove the quality culture change across GE Healthcare in the late 1990s.
Dr. Jonathan Rubin is the Martel Collegiate Professor of Radiology and section head for Ultrasound and Abdominal Interventional Radiology at the University of Michigan Medical School.
Dr. Rubin has over 200 peer-reviewed publications, over 125 invited presentations and 10 patents. In 2005 he was awarded the University of Michigan Medical School Innovation Award. In 2007 he won the American Institute of Ultrasound in Medicine Joseph H. Holmes Clinical Pioneer Award. In 2011 he received the Society of Radiologists in Ultrasound Lawrence Mack Lifetime Achievement Award. From 1979 to 1984, Dr. Rubin was the director of the Section of Body Computed Tomography and Ultrasound Imaging in the Department of Radiology at the University of Chicago.
Dr. Rubin received a bachelor’s in chemistry from the University of Utah. He received an M.D. from the University of Chicago Pritzker School of Medicine and a Ph.D. in biophysics and theoretical biology from the University of Chicago.
Dr. Malik is currently the Director of Hepatology and Associate Chief, Division of Gastroenterology at Tufts Medical Center. He has made important research findings in the field of non-invasive diagnosis of liver fibrosis and cirrhosis, Hepatitis B and C, NASH, liver failure and liver cancer. Previously, he served as Staff Physician and Attending Physician in Hepatology and Transplant Hepatology at Harvard Medical Faculty Physicians. In his role as the Medical Director of the Hepatology & Hepatobiliary Program at Beth Israel Deaconess Medical Center, Harvard Medical School, he set up and developed the nationally recognized multidisciplinary programs in liver failure and liver cancer.
Prior to this, he was a Staff Physician in Hepatology on the Faculty of Medicine at the Royal Free Hospital and University College Hospital, University College London. Dr. Malik completed his M.D. at Kings College London and Ph.D. in liver cell biology and hepatology at University College London. He completed advanced training in hepatology and transplantation medicine at the Roger Williams Liver Unit at Kings College Hospital, the Sheila Sherlock Liver Unit at the Royal Free Hospital and at the Beth Israel Deaconess Medical Center, Harvard Medical School.
Dr. Jing Gao is currently associate professor of ultrasound at Rocky Vista University in Ivins, Utah. Dr. Gao is also an adjunct assistant research professor of radiology at Weill Cornell Medicine in New York, N.Y.
Dr. Gao brings over 30 years of clinical and research experience in abdominal ultrasound, in both the United States and China. Besides her post at Rocky Vista, Dr. Gao is also deputy president and guest professor at the Dalian University International Institute of Medical Imaging in China.
Dr. Gao has numerous peer reviewed publications in the areas of liver, spleen and kidney diseases and quantitative ultrasound imaging. Her numerous honors and professional affiliations include being named one of China’s Top 100 Ultrasound Physicians by the Chinese Association of Medical Imaging Technology, and she was appointed as the ambassador for research & education collaboration between the American institute of Ultrasound in Medicine and Chinese Ultrasound Doctor’s Association in April 2019.
She is a fellow of the Chinese Association of Ultrasound in Medicine and Biology, a fellow of the American Institute of Ultrasound in Medicine and an editorial board member of Clinical Imaging (Elsevier) and Ultrasound in Medicine and Biology (Elsevier).
Dr. Gao completed her medical education at Changchun and Dalian Medical Colleges in China.
ENDRA operates a Quality Management System which complies with the requirements of ISO 13485:2016 & EN ISO 13485:2016 for the following scope:
Certificate number: MD 697226
Effective Date: 2019-04-02
Expiry Date: 2022-04-01